Eczema screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Hanifin and Rajka criteria]] are the gold standard for diagnosing [[eczema]]. It should satisfy 3 out of 4 [[major criteria]], or 3 out of 23 [[minor criteria]]. <ref name="pmiddoi: 10.1016/j.jaad.2013.10.010.">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi: 10.1016/j.jaad.2013.10.010. | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref> [[United Kingdom Working Party diagnostic criteria]] is another alternative method of diagnosing eczema which requires 1 mandatory criterion and 5 major criteria, and no laboratory testing is needed. <ref name="pmid7918017">{{cite journal| author=Williams HC, Burney PG, Pembroke AC, Hay RJ| title=The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. | journal=Br J Dermatol | year= 1994 | volume= 131 | issue= 3 | pages= 406-16 | pmid=7918017 | doi=10.1111/j.1365-2133.1994.tb08532.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7918017 }} </ref> <ref name="pmiddoi: 10.1111/j.1468-3083.2006.01664.x.">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi: 10.1111/j.1468-3083.2006.01664.x. | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref> To assess the long-term control of this [[disease]], three methods are used, namely the repeated measurement of [[outcomes]], the number of [[medications]] used, and the occurrence of [[flares]] or [[remissions]].<ref name="pmid27522613">{{cite journal| author=Barbarot S, Rogers NK, Abuabara K, Aubert H, Chalmers J, Flohr C | display-authors=etal| title=Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review. | journal=J Am Acad Dermatol | year= 2016 | volume= 75 | issue= 5 | pages= 1038-1044 | pmid=27522613 | doi=10.1016/j.jaad.2016.05.043 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27522613 }} </ref> | |||
==Eczema screening== | ==Eczema screening== | ||
Revision as of 23:18, 25 May 2022
|
Eczema Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Eczema On the Web |
|
American Roentgen Ray Society Images of Eczema |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.
Overview
Hanifin and Rajka criteria are the gold standard for diagnosing eczema. It should satisfy 3 out of 4 major criteria, or 3 out of 23 minor criteria. [1] United Kingdom Working Party diagnostic criteria is another alternative method of diagnosing eczema which requires 1 mandatory criterion and 5 major criteria, and no laboratory testing is needed. [2] [3] To assess the long-term control of this disease, three methods are used, namely the repeated measurement of outcomes, the number of medications used, and the occurrence of flares or remissions.[4]
Eczema screening
- Hanifin and Rajka criteria is the gold standard for diagnosing eczema.
- Three out of 4 major criteria, or 3 out of 23 minor criteria should be satisfied.
- Another alternative method is the United Kingdom Working Party diagnostic criteria which only requires 1 mandatory criterion, and 5 major criteria, and no laboratory testing is required.
- Three methods are used to assess the control of the disease, namely the repeated measurement of outcomes, the number of medications used, and the occurrence of flares or remissions.
References
- ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1016/j.jaad.2013.10.010. doi: 10.1016/j.jaad.2013.10.010. Check
|pmid=value (help). - ↑ Williams HC, Burney PG, Pembroke AC, Hay RJ (1994). "The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation". Br J Dermatol. 131 (3): 406–16. doi:10.1111/j.1365-2133.1994.tb08532.x. PMID 7918017.
- ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1111/j.1468-3083.2006.01664.x. doi: 10.1111/j.1468-3083.2006.01664.x. Check
|pmid=value (help). - ↑ Barbarot S, Rogers NK, Abuabara K, Aubert H, Chalmers J, Flohr C; et al. (2016). "Strategies used for measuring long-term control in atopic dermatitis trials: A systematic review". J Am Acad Dermatol. 75 (5): 1038–1044. doi:10.1016/j.jaad.2016.05.043. PMID 27522613.